Boston Scientific announces favorable study data for its FARAPULSE PFA system and WATCHMAN FLX device at the AF Symposium 2025.
Boston Scientific (BSX) closed the most recent trading day at $98.66, moving +0.5% from the previous trading session.
Boston Scientific's recent acquisitions have added numerous products with immense potential.
Boston Scientific Corporation (BSX) shares rise on acquisitions – earnings due in early February.
The latest trading day saw Boston Scientific (BSX) settling at $94.61, representing a -0.28% change from its previous close.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.
On Wednesday, Boston Scientific Corporation BSX agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and peripheral artery disease.
Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Boston Scientific successfully continues its expansion of operations across different geographies outside the United States.
In the most recent trading session, Boston Scientific (BSX) closed at $91.29, indicating a +0.66% shift from the previous trading day.
Here is how Boston Scientific (BSX) and Aclarion, Inc. (ACON) have performed compared to their sector so far this year.